SCHEMBL8353441

SCHEMBL8353441

Cn1cnc2c(N(Cc3ccccc3)Cc3ccccc3)nc(CF)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 6/20 0.44
MAPT P10636 3/20 0.41
TP53 P04637 1/20 0.41
MAPK1 P28482 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CCNA1 P78396 2/20 0.41
CDK5 Q00535 2/20 0.41
CYP3A4 P08684 2/20 0.41
ALOX15 P16050 2/20 0.41
APOBEC3A P31941 1/20 0.41
CCNB2 O95067 1/20 0.41
CCNE2 O96020 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
GAA P10253 1/20 0.41
CYP2D6 P10635 1/20 0.41
CCNB1 P14635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4462535 0.88 CDK1 (0.44) CDK1MAPTTP53MAPK1TDP1
SCHEMBL4564902 0.84 CDK1 (0.46) CDK1MAPTTP53MAPK1TDP1
SCHEMBL4458806 0.83 PDE4A (0.49) CDK1MAPTTP53MAPK1TDP1
SCHEMBL4452461 0.83 CYP3A4 (0.51) CDK1MAPTTP53MAPK1TDP1
SCHEMBL380633 0.82 CDK1 (0.62) CDK1MAPTTP53MAPK1TDP1
SCHEMBL13866472 0.82 CDK1 (0.62) CDK1MAPTTP53MAPK1TDP1
SCHEMBL4464767 0.80 CDK1 (0.47) CDK1MAPTTP53MAPK1TDP1
SCHEMBL14400799 0.80 CDK1 (0.48) CDK1MAPTTP53MAPK1TDP1
SCHEMBL8353775 0.78 CDK1 (0.44) CDK1MAPTTP53MAPK1TDP1
SCHEMBL8353365 0.77 CDK1 (0.42) CDK1MAPTTP53MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003011864-A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2003-02-13 WO disclosed